Projects per year
Fingerprint Dive into the research topics where Mujeeb Shad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Schizophrenia
Medicine & Life Sciences
Drug Interactions
Medicine & Life Sciences
Neurobiology
Medicine & Life Sciences
Bipolar Disorder
Medicine & Life Sciences
Prefrontal Cortex
Medicine & Life Sciences
Antipsychotic Agents
Medicine & Life Sciences
Psychiatry
Medicine & Life Sciences
Risperidone
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2012
- 1 Finished
Neurobiology
Schizophrenia
Magnetic Resonance Imaging
Research
Brain
Research Output 1997 2019
Aripiprazole-induced kleptomania: Case report
Jones, R. & Shad, M., Feb 1 2019, In : Journal of Affective Disorders. 244, p. 242-243 2 p.Research output: Contribution to journal › Letter
Disruptive, Impulse Control, and Conduct Disorders
Aripiprazole
Can low-dose aripiprazole reverse some of the adverse effects from a long-acting injectable?
Fryefield, K. & Shad, M., Feb 1 2019, In : Schizophrenia Research. 204, p. 417-418 2 p.Research output: Contribution to journal › Letter
Injections
Aripiprazole
How to identify and manage non-response to clozapine?
Shad, M., Felzien, E., Roy, K. & Sethi, S., Oct 1 2019, In : Asian Journal of Psychiatry. 45, p. 50-52 3 p.Research output: Contribution to journal › Article
Clozapine
Antipsychotic Agents
Social Adjustment
Therapeutics
Ciprofloxacin
1
Citation
(Scopus)
Efficacy of Dextromethorphan/Quinidine for Patients With Psychosis-Related Aggression: A Retrospective Case Series
Chen, Q. L., Calcagno, H. E. & Shad, M., Jun 28 2018, In : The primary care companion for CNS disorders. 20, 3Research output: Contribution to journal › Article
Dextromethorphan
Quinidine
Aggression
Psychotic Disorders
Impulsive Behavior
Glabellar Botulinum Toxin Injections in Major Depressive Disorder: A Critical Review
Stearns, T. P., Shad, M. & Guzman, G. C., Oct 4 2018, In : The primary care companion for CNS disorders. 20, 5Research output: Contribution to journal › Article
Type A Botulinum Toxins
Botulinum Toxins
Major Depressive Disorder
Injections
Clinical Trials